► Members
► Trials
► Downloadables
► Information
► Tips
► EAA Supports
Latest Eczema Trials 2022
New South Wales
- Adults With Moderate to Severe Atopic Dermatitis
- The Hillier Study
- The Skin Hospital Clinical Trial
- Endor Natural Product Clinical Trial
- A Study to Evaluate Upadacitinib With Topical Corticosteroids
- A Study of Baricitinib in Children
Queensland
- Adults With Moderate to Severe Atopic Dermatitis
- The Hillier Study
- A Study to Evaluate Upadacitinib With Topical Corticosteroids
- A Study to Evaluate Upadacitinib
- A Study of Baricitinib in Children
Western Australia
Victoria
- Adults With Moderate to Severe Atopic Dermatitis
- Sinclair Dermatology Atopic Dermatitis
- The Hillier Study
- Victoria University Atopic Dermatitis Study
- Can Vitamin D Supplementation in Infants Prevent Food Allergy
- A Study to Evaluate Upadacitinib
- Testing for Preventing Eczema and Food Allergy in Infants
- A Study of Baricitinib in Children
South Australia
Tasmania
Northern Territory
Australian Capital Territory
It is not the policy of the Eczema Association of Australasia Inc to recommend or endorse any product or treatment.
It is part of the role of the Association to provide information on a wide range of products and treatments to keep those involved with eczema as fully informed as possible as to all options available. For medical advice, consult your health professional.